NCT02694783View on ClinicalTrials.gov

Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 28, 2016

Primary Completion Date

December 13, 2019

Study Completion Date

March 6, 2020

Conditions
Progressive Multifocal Leukoencephalopathy
Interventions
BIOLOGICAL

PyVST

ex vivo generated polyomavirus-specific T cells from HLA-matched donor

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT02694783 - Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells | Biotech Hunter | Biotech Hunter